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Abstract
Background: The movement of evidence-based practices (EBPs) into routine clinical usage is not spontaneous, but
requires focused efforts. The field of implementation science has developed to facilitate the spread of EBPs, including
both psychosocial and medical interventions for mental and physical health concerns.
Discussion: The authors aim to introduce implementation science principles to non-specialist investigators,
administrators, and policymakers seeking to become familiar with this emerging field. This introduction is based
on published literature and the authors’ experience as researchers in the field, as well as extensive service as
implementation science grant reviewers.
Implementation science is “the scientific study of methods to promote the systematic uptake of research findings
and other EBPs into routine practice, and, hence, to improve the quality and effectiveness of health services.”
Implementation science is distinct from, but shares characteristics with, both quality improvement and dissemination
methods. Implementation studies can be either assess naturalistic variability or measure change in response to planned
intervention. Implementation studies typically employ mixed quantitative-qualitative designs, identifying factors that
impact uptake across multiple levels, including patient, provider, clinic, facility, organization, and often the broader
community and policy environment. Accordingly, implementation science requires a solid grounding in theory and the
involvement of trans-disciplinary research teams.
Summary: The business case for implementation science is clear: As healthcare systems work under increasingly
dynamic and resource-constrained conditions, evidence-based strategies are essential in order to ensure that research
investments maximize healthcare value and improve public health. Implementation science plays a critical role in
supporting these efforts.
Keywords: Implementation, Quality Improvement, Health Services, Outcome Assessment, Evidence-Based Practice,
Learning Healthcare Organization
Background: what is implementation science and
how did it develop?
The need for a science of implementation
It has been widely reported that evidence-based prac-
tices (EBPs) take on average 17 years to be incorporated
into routine general practice in health care [1–3]. Even
this dismal estimate presents an unrealistically rosy pro-
jection, as only about half of EBPs ever reach widespread
clinical usage [1].
Historically, this research-to-practice gap has not
been the concern of academic clinical researchers. The
traditional academic business case for career success
has primarily supported conducting descriptive or
mechanism-oriented studies and intervention studies
on highly selected, typically academic medical center-
based populations, and publishing in—ideally—top
quality academic journals. Whether these findings
translate into public health impact has typically not
been the concern of traditional healthcare researchers.
This paradigm for academic success has justly come
under criticism in recent years. Payers for biomedical re-
search have been concerned over the lack of public
health impact of their research dollars [4]. Moreover,
decreasing research funding world-wide has led to
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debates over the trade-offs between investing in more
conservative projects with predictable results versus
more innovative research, including projects involving
more real-world samples that could result in greater
public health impact [5].
Recognition of the need for research that more directly
impacts public health has broadened the academic
mindset somewhat, from an exclusive emphasis on effi-
cacy studies to more broadly generalizable effectiveness
trials (Table 1) [6]. Several overlapping names, and con-
ceptual structures, have developed for these latter types
of trials including “effectiveness trials” [7, 8] “pragmatic
clinical trials” [9]“practical clinical trials” [10] and “large
simple trials” [11].
However, such trials in and of themselves provide little
guarantee of public health impact. Effectiveness trials typ-
ically depend, like efficacy trials, on a research resources
which are separate from the clinical infrastructure and
which are externally funded, time-limited, and evanescent
at the end of the protocol [8]. Research-supported re-
sources seldom remain at local sites to support continued
use of even successful interventions; there is typically little
institutional memory for the intervention, and no technol-
ogy transfer. Moreover, EBPs often have characteristics
that make unassisted translation into practice unlikely, es-
pecially if the intervention requires incorporating a change
in a clinician’s routine [12].
A useful conceptualization of the biomedical research
process has been as a “pipeline” [13] whereby an inter-
vention moves from efficacy through effectiveness trials
to sustained application in general practice. Blockages
can appear at various stages, leading to quality gaps as
EBPs are applied in less controlled settings. Many factors
can impede EBP uptake, including competing demands
on frontline providers; lack of knowledge, skills and re-
sources; and misalignment of research evidence with
operational priorities can all impede uptake. Accord-
ingly, there is clear need to develop specific strategies to
promote the uptake of EBPs into general clinical usage
[14]. Implementation science has developed to address
these needs.
The organization of this summary
The aim of this review is to introduce non-specialist
investigators, administrators, and policymakers to the
principles and methods of implementation science. We
compiled this review based on published literature, our
experience as practicing implementation researchers,
and extensive service on implementation science grant
review committees. We include examples to illustrate
critical principles, utilizing primarily studies of psycho-
social EBPs. Most of these examples come from studies
funded by the US Department of Veterans Affairs
(USVA), since we are able to present these cases with a
look “behind the scenes” to provide insights that may
not be evident from simply reading the published results.
However, it is important to note that the field of imple-
mentation science is a global field, as perusal of some of
the major publication venues will make evident, such as
Implementation Science, BMC Health Services Research,
and a variety of specifically themed journals.
In this review we first define implementation science,
comparing and contrasting it to the methods of quality
improvement and dissemination. We then trace the de-
velopment of implementation science as a field, illustrat-
ing this trajectory with experience in the USVA. We
then drill down into the field, beginning with the basics
of descriptive methods, including the pivotal role played
Table 1 Characteristics of Efficacy vs. Effectiveness Trial Designs (after [8])
Efficacy Trial Effectiveness Trial
Validity Priority Internal > External External≥ Internal
Population and
Sample
• Highly selected for condition of interest, narrowly defined • Selected for condition of interest, reflecting presentation in
source population
• Few comorbidities • Comorbidities resemble those in population to which results will
be applied; only those who cannot practically or ethically
participate are excluded• Willing and motivated participants
Intervention • Intervention staff are highly qualified • Staff selection, training, and fidelity monitoring resemble those
likely to be feasible in target sites outside of the protocol proper
• Training may be intensive
• Fidelity monitoring may be similarly intensive
Outcome
Measures and
Data Collection
• Outcome measurements can be extensive, casting a wide
net for potential secondary effects, moderators and
mediators, or adverse effects
• Outcome batteries minimize respondent burden (in terms of
both frequency and length of assessments) since subjects are
heterogeneous in their willingness and capability to participate
• Since subjects are motivated, respondent burden less of a
concern
• Accordingly, outcome measures chosen carefully to target fewer
outcomes, and must be simple to complete
Data Analysis • Standard statistical approaches suffice, and data-intensive
analyses may be feasible
• Analyses to account for greater sample heterogeneity
• Analyses account for more missing data and data not missing at
random
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by theories, models, and frameworks. Next we introduce
the fundamentals of controlled intervention trials, includ-
ing the quickly developing area of hybrid effectiveness-im-
plementation designs. We next provide a detailed
description of two real-world implementation studies,
and close by placing implementation science into the
context of global health policy.
Defining implementation science
Implementation science can be defined as “the scientific
study of methods to promote the systematic uptake of
research findings and other evidence-based practices
into routine practice, and, hence, to improve the quality
and effectiveness of health services” [15]. This field in-
corporates a scope broader than traditional clinical re-
search, focusing not only at the patient level but also at
the provider, organization, and policy levels of healthcare
(Table 2). Accordingly, implementation research requires
trans-disciplinary research teams that include members
who are not routinely part of most clinical trials such as
health services researchers; economists; sociologists; an-
thropologists; organizational scientists; and operational
partners including administrators, front-line clinicians,
and patients.
Implementation sciences, quality improvement, and
dissemination
Both implementation science and quality improve-
ment (QI) efforts share the ultimate goal of improving
the quality of healthcare. Methods used in the two
fields often overlap, although there are some differ-
ences. QI efforts usually begin with a specific problem
in a specific healthcare system, recognized at the level
of the provider, clinic, or health system, and lead to
the design and trial of strategies to improve a specific
problem for that specific healthcare system. A variety
of QI approaches have developed, often taken from
other industries such as Toyota Lean, Six Sigma, and
others [16, 17].
In contrast, implementation science typically begins
with an EBP that is under-utilized, and then identifies and
addresses resultant quality gaps at the provider, clinic, or
healthcare system level. Additionally, implementation sci-
ence, as a science, takes as part of its mission an explicit
goal of developing generalizable knowledge that can be
widely applied beyond the individual system under study.
Nonetheless, both approaches share a common goal, value
system, desire for rigor, focus on outcomes, and many
common methods.
Dissemination, in contrast to implementation, refers to
the spread of information about an intervention, assisted
at most by educational efforts [18]. Again, however,
there is some overlap in that implementation efforts
may incorporate dissemination techniques, but they are
typically embedded in more comprehensive, targeted,
and active efforts to spread the EBP.
Development of implementation science
Over the past 10–15 years healthcare systems that carry
responsibility for managing fixed budgets to care for
their populations have become increasingly attentive to
problems of implementation in order to maximize the
value of their healthcare funds [19]. Such organizations
include several countries’ national health services, and
the USVA in the United States. More recently in the US,
new laws such as the Affordable Care Act have led to
Table 2 Types of Studies to Address Blockages in the Implementation Process
Implementation Process Gap Types of Studies
Limited external validity of efficacy/effectiveness
studies
• Design clinical interventions ready for implementation earlier in the research pipeline,
emphasizing tools, products, and strategies that mitigate variations in uptake across
consumer, provider, and or organizational contexts
Quality gaps across systems due to variations in
organizational capacity (e.g., resources, leadership)
• Assess variations and customize implementation strategies based on organizational
context
• Data infrastructure development to routinely capture or assess implementation fidelity,
patient-level processes/outcomes of care, and value/return-on-investment measures
• Further refinement of implementation strategies involving organizational and/or provider
behavior change
• Development of provider/practice networks to conduct implementation studies or evaluation
of national programs
Frontline provider competing demands
(e.g., multiple clinical reminders)
• Refinement of implementation strategies using cross-disciplinary methods that address provider
behavior/organizational change (e.g., business, economics, policy, operations research. etc.)
• Positive deviation or adaptation studies especially to improve implementation at lower-
resourced, later-adopter sites
Misalignment with national or regional priorities • National policy/practice roll-outs
• Randomized evaluations of national programs or policies
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the development of accountable care organizations,
which align care providers, often across hospital systems,
and which frequently manage care for a given population
under a fixed or constrained reimbursement cap [20]. As
a result, US federal research funding organizations have
recently developed an investment in implementation sci-
ence [21, 22]. Another North American program, Know-
ledge Translation Canada [23], strives to improve the
impact of research findings through implementation sci-
ence strategies.
Among the oldest and most extensive scientific pro-
grams focusing on implementation is the USVA’s Quality
Enhancement Research Initiative (QUERI; [13]), which
we provide as a case study in the development of
implementation science as a field. Since its inception in
1998, the goal of QUERI has been to improve military
veterans’ health by supporting the more rapid move-
ment of effective interventions into practice [24].
QUERI combines scientific rigor provided by leading
academic researchers with partnerships with USVA
operations leaders who face pressing implementation is-
sues. QUERI is uniquely positioned as an implementation
science resource within a national healthcare system, and
as a result provides significant academic-operations syner-
gies: QUERI focuses on increasing the health system
impact of EBPs of clinical and policy importance to VA
operations, and through scientific rigor contributes foun-
dational knowledge to the field of implementation science
which can have impact well beyond the USVA system
itself.
Reflecting the development of implementation science
as a field, QUERI’s first evolutionary leap was its transi-
tion from investment in conventional health services
research studies to research that focused on description
of gaps in the use of EBPs and description of relevant
barriers and facilitators. The second evolutionary leap,
which is currently ongoing, is a transition from descrip-
tive studies of barrier/facilitators to specifying and test-
ing optimal strategies for implementation, including
both controlled trials and observational studies that
evaluate natural experiments of practice-based improve-
ment initiatives. Most recently, QUERI’s mission has
extended to support implementation of EBPs, as pro-
moted by the US Office of Management and Budget [25]
through the use of rigorous evaluation to study and
scale-up programs or initiatives that have demonstrated
effectiveness, or use randomized program design to test
policies or programs at a population level [26, 27].
Discussion: the principles and methods of
implementation science
Implementation Studies Differ from Clinical Studies
The first step in understanding implementation studies is
to distinguish implementation processes from the EBPs
they seek to implement. An implementation intervention
is “a single method or technique to facilitate change,”
while an implementation strategy is “an integrated set,
bundle, or package of discreet implementation interven-
tions ideally selected to address specific identified barriers
to implementation success” [13]. Implementation inter-
ventions may include, for example, efforts to change be-
havior at the patient, provider, system, or even policy level.
Common examples include strategies at the provider level
such as education/training, audit-feedback, and perform-
ance incentives. Strategies targeting the provider, team, or
clinic levels may include QI techniques or other systems
redesign efforts, team-based performance incentives,
learning collaboratives, or community-engagement. Facili-
tation, guided efforts by internal or external organizational
staff to support multiple levels of system change through
provider or team-based coaching, is increasingly recog-
nized as critical to the success of many implementation
effects [28, 29].
In contrast to clinical research, in which typically
focuses on the health effects of an EBP, implementation
studies typically focus on rates and quality of use of
EBPs rather than their effects. Such EBPs may be as
“simple” as increasing use of a single medication such as
beta-blockers in individuals who have experienced a
myocardial infarction or the use of metabolic side effect
monitoring for individuals taking antipsychotic medica-
tions, or as complex as instituting psychotherapies like
cognitive-behavioral therapy or even multi-component
care paradigms such as the collaborative chronic care
model [30].
While the distinction between the implementation
strategy and the EBP seems clear in concept, careful at-
tention to their distinct roles is imperative in developing
focused hypotheses and making evaluation design deci-
sions. For instance, in studying the effects of a program
to increase effective cognitive-behavioral therapy use for
bipolar disorder, the impact of cognitive-behavioral ther-
apy on health status would be an EBP outcome (and
more typically a focus for a clinical study), while measur-
ing the proportion of clinicians providing cognitive-
behavioral therapy, or proportion of patients who attend
a minimum level of cognitive-behavioral therapy sessions
would be a more typical implementation study outcome.
Evaluating the implementation process and its impact
Thus the crux of implementation studies is their focus
on evaluating the process of implementation and its
impact on the EBP of interest. These studies can
involve one or more of three broad types of evaluation,
process evaluation, formative evaluation, and summa-
tive evaluation [13, 31].
Process evaluation simply describes the characteristics
of use of an EBP (or lack thereof ). Data are collected
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before, during, and/or after the implementation and ana-
lyzed by the research team without feedback to the
implementation team and without intent to change the
ongoing process. Process evaluation can be undertaken
in a purely observational study (e.g., in preparation for
developing an implementation strategy) or during the
course of a spontaneous or planned system or policy
change.
Formative evaluation utilizes the same methods as
process evaluation, but differs in that data are fed back
to the implementation team and/or staff in the target
system during the study in order to adapt and improve
the process of implementation during the course of the
protocol. Formative evaluation is conceptually similar to
fidelity monitoring that goes on as part of any traditional
clinical trial, but differs in that it is specified a priori in a
study hypothesis or research question.
A quantitative version of formative evaluation in clin-
ical trials is the use of sequential multiple assignment
randomized trials (SMART) or adaptive intervention
designs, which are used to either augment or switch
treatments at critical decision points where there is evi-
dence of initial non-response [32, 33]. As we discuss
below, the use of formative evaluation has implications
for controlled trial validity, which may differ between
clinical and implementation trials.
Summative evaluation is a compilation, at study end,
of the impact of the implementation strategy. Summative
evaluation measures typically assess impacts on pro-
cesses of care (e.g., increased use or quality of targeted
EBP). Another common component of summative evalu-
ation is to characterize the economic impact of an
implementation strategy and its effects. Implementation
studies most commonly do not employ formal cost-
effectiveness analyses but conduct focal “business impact
analyses” [34]. Such analyses focus on estimating the
financial consequences of adoption of a clinical practice
within a specific healthcare setting or system. Typically
this includes costs to the system associated with both
the implementation strategy and the utilization of the
EBP.
Types of evaluation data
Data for the process, formative, and/or summative
evaluation can come from various sources and can
include either or both of quantitative and qualitative
data. Data can be collected across various levels of
observation including patients; providers; systems; and
broader environmental factors such as community, pol-
icy, or economic indices.
Common quantitative measures include structured
surveys and tools that assess, for example, organizational
context, provider attitudes and behaviors, or patient
receptivity to change. Administrative data are often
utilized, either in focal target populations or at the
broader system level to characterize, for example, base-
line and change in rates of utilization of particular prac-
tices. Measures of fidelity to the EBP are often central
components of the evaluation plan, and these can be
quantitative, qualitative, or both.
Common qualitative data collection methods include
semi-structured interviews with patients, providers, or
other stakeholders; focus groups; direct observation of
clinical processes; and document review. Qualitative data
collection and analysis can either be structured as a
hypothesis-free exploration using grounded theory or
related approaches [35] or can utilize directed content
analysis [36] to address pre-specified issues such as
hypothesis-testing or measurement of intervention fidel-
ity. Most implementation evaluation processes include
mixed qualitative and quantitative measures, and require
careful attention in the study design to the various ways
to combine such data [37].
The role of theory and its link to specific design
decisions
The need for theory-based implementation
Describing, implementing, and then sustaining any
innovation is a complex undertaking [38] —complex
because implementation strategies (a) are typically
multi-component and (b) must adapt to local contexts.
Contexts in which implementation efforts occur are
themselves complex because of multiple interacting
levels (e.g., patients, providers, teams, service units), with
wide variation from setting to setting [39]. Without a
thorough understanding of the context, an EBP may
either not be adopted or may be taken up in an adapted
form with compromised fidelity due to contextual pres-
sures. The endeavor requires clear, collective, consistent
use of theory to build knowledge about what works,
where, and why [40].
Theories, models, and frameworks
The terms theory, model, and framework are, unfortu-
nately, often used interchangeably and imprecisely. Use
of the term theory in this paper refers to any proposal
about meaningful relationships between constructs (vari-
ables) or how a mechanism or construct may change the
behavior of another construct or outcome [41, 42].
A theory may be operationalized within a model,
which is a simplified depiction of a more complex world
with relatively precise assumptions about cause and
effect. For example, the model in Fig. 1 depicts a single
hypothesized pathway of change for implementing a
weight management program [43, 44]. This model
hypothesizes that leadership engagement will result in
sufficient resources for implementation, and in leaders’
articulating implementation goals that align with
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organizational priorities. These leadership actions serve
to raise organizational perceptions of priority, which in
turn leads to positive implementation outcomes (e.g.,
high fidelity of the program to its intended design), and
thus to better weight loss for patients. Each construct in
the model can be assessed and the model tested to af-
firm or disprove this pathway of change. Based on re-
sults, the model may need refinement or be rejected
altogether.
Frameworks provide a broad set of constructs that
organize concepts and data descriptively without specify-
ing causal relationships. They may also provide a prescrip-
tive series of steps summarizing how implementation
should ideally be planned and carried out [13, 45]. For
example, the Consolidated Framework for Implementa-
tion Research (CFIR, [46]) classifies 39 implementation
constructs across five domains considered to be influential
moderators or mediators of implementation outcomes,
providing a structure by which to systematically assess
context within which implementation occurs [47]. Opti-
mally, researchers will also circle back and utilize empir-
ical data to assess the usefulness of the guiding theories,
models, or frameworks used to design the study and offer
recommendations to improve them [48]. Consistent use
of constructs across studies further allows more efficient
syntheses through use of e.g., qualitative comparative ana-
lyses techniques [49]. Explicit operationalization of theor-
etical constructs can also guide development of robust
quantitative measures [50, 51].
Example: using a framework to guided data collection
and analysis
An example will illustrate the role of such frameworks.
Damschroder and Lowery conducted an evaluation of a
weight management program in USVA, funded by the
QUERI program described above [43, 44]. There was
wide variation in program implementation 1.5 years after
initial dissemination. CFIR was used to develop a guide
to interview staff at local facilities to understand what
contributed to this variation. Quantitative ratings were
applied to qualitatively coded interview data [36] and
used to identify constructs that distinguished between
sites with better versus worse implementation outcomes.
Ten constructs were found to be related to successful
implementation. For example, the sites with the poorest
implementation outcomes had lower ratings for “Goals
and Feedback” because staff at these sites did not have the
time or skills to identify program goals or monitor pro-
gress toward those goals. This information can be used to
develop more specific models to guide future implementa-
tions and identify discrete implementation strategies (e.g.,
audit-feedback [52], identify champions [53]).
Controlled implementation trials
Types of controlled implementation trials
Many implementation studies seek to identify barriers
and facilitators of EBP adoption under naturalistic con-
ditions. However, other studies seek to enhance EBP
adoption by employing specific implementation strat-
egies in controlled trials. Controlled implementation trial
designs are of two major types: parallel group and inter-
rupted time series. Parallel group designs are random-
ized and prospective, similar to other types of health
services or clinical trials. The unit of randomization de-
pends on the strategy and the outcome of interest, and
may be the patient, provider, clinic, facility, or system
level. Some creative designs respond to real-world con-
straints by combining characteristics of historical control
studies with true matched randomization [28]. Add-
itional innovative designs have been employed, such as
stepped wedge designs in which all participating sites
receive implementation support, though staggered in
time [54, 55], resembling traditional incomplete block
designs. Additionally, controlled implementation trials
sometimes randomize a small number of sites and measure
outcomes at the individual patient level, utilizing multivari-
ate nested analyses [56]. Finally, SMART randomization
designs, as mentioned above [32], can bring an added
degree of rigor to the use of within-study formative
evaluation.
In the real world of policy roll-outs and program
changes, parallel group designs may not be feasible for
pragmatic, political, or ethical reasons. In such situa-
tions, interrupted time series designs can be utilized.
These also resemble their counterparts among health
services and clinical trials, optimally with the implemen-
tation outcome of interest measured at multiple time
points prior to and after an implementation effort. Such
designs are most feasible when the implementation strat-
egy is a discrete event, such as a policy change [57] since
Fig. 1 Model of a Hypothesized Pathway of Change
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more typical implementation strategies exert their effect
over months, making the “interruption” in the time
series more difficult to pinpoint.
Implementation versus traditional health services and
clinical trials
Controlled implementation trials differ from other
types of health services and clinical trials in two major
ways. First and most basically, as noted above, they
focus on the impact of the implementation strategy on
the use of an EBP, rather than health impact of the EBP
itself. Second, they take a fundamentally different ap-
proach to validity, as illustrated below.
Consider a hypothetical trial of motivational interviewing
(MI) for substance use disorders in the homeless popula-
tion (Table 3). Implementation designs differ from the
intervention trials at a basic level, that of the hypothesis.
While intervention trials focus on comparing the inter-
vention to a comparison group, implementation trials
focus on the ability of the research team to increase
adoption of MI. While the population and setting may
resemble that for effectiveness trials, the unit of obser-
vation in implementation trials may be providers or
clinics—depending on the focus of the implementation
efforts. As the population becomes more heteroge-
neous, outcome measures must become briefer and sim-
pler in order to minimize the respondent burden and
retain in the protocol subjects who are less research-
tolerant. As one moves from left to right in Table 3,
intervention clinicians become progressively less highly
specialized and skill development efforts more closely
resemble training that would typically be feasible under
clinical conditions; measurement of fidelity to the inter-
vention varies similarly.
The consideration of the context for the research also
differs substantively. Efficacy trials value conducting a
trial that is invariant from beginning to end. This entails
sometimes extra-ordinary efforts at training clinicians
and tracking subjects, so that the research team’s efforts
amount at times to “crypto-case management”—which is
not a problem since the focus of the trial is solely on
testing the intervention under optimal conditions. How-
ever, since effectiveness studies are more concerned with
performance of an efficacious intervention in real-world
settings, careful attention is paid to limiting the amount
of research-funded effort that is incorporated into the
protocol, often “firewalling” research effort with carefully
and explicitly defined parameters (e.g., 8). Further, for
implementation trials, trying to optimize the natural
context in which adoption is being measured is a threat
to validity of the trial. Thus researcher involvement in
the site of adoption is drastically circumscribed, with
some implementation trials even limiting research sup-
port to training endogenous clinicians and utilizing re-
mote, “light-touch” outcome assessments for patient and
provider subjects.
These differences are driven by radically different pri-
orities regarding trial validity [58]. Internal validity pri-
oritizes establishing a causal connection between the
intervention and the outcome; in the service of this aim,
sample, outcome measurements, intervention are all
highly controlled without consideration of applicability
to other considerations outside of the trial itself. Exter-
nal validity prioritizes the generalizability of trial results
to other relevant populations and situations. While effi-
cacy studies value internal over external validity, the bal-
ance shifts for effectiveness studies: Although the
effectiveness trial must have sufficient internal validity to
Table 3 Intervention vs. Implementation Trial Design Perspectives: A Hypothetical Example of the Use of Motivational Interviewing
(MI) for Substance Use Disorders in the Homeless Population
Efficacy Design Principles Effectiveness Design Principles Implementation Design Principles
Hypothesis MI beats control MI beats control MI will be adopted and sustained
Population &
setting
Exclude psychosis, bipolar,
anxiety; any setting with
cooperative patients
Include most comorbidities;
typical setting is nonspecialized
practice sites
Unit of observation may be patients, providers, or clinics; typical
setting is nonspecialized practice sites
Outcome
measures
Health outcomes, many: "just in
case…"
Health outcomes, short & sweet Emphasize MI adoption measures
Intervention:
clinicians
PhDs, MSWs hired & trained by
PI
Addiction counselors hired as
study staff
Endogenous addiction counselors
Intervention:
fidelity
Trained to criterion, audiotaped
for fidelity
Trained to criterion, QI-type
monitoring as in clinical system
Formative evaluation the focus
Context Make sure that the trial is
successful, at all costs
Work within “typical” conditions Maintain typical conditions
Research
support
Crypto-case management Research support, but
“firewalled”
Research support limited; e.g., only for training
Validity
emphasis
Internal > > external External > internal Plan to optimize protocol in real time using formative evaluation,
in violation of “traditional” considerations of internal validity,
while systematically documenting adaptations
Bauer et al. BMC Psychology  (2015) 3:32 Page 7 of 12
carry out the study successfully, explicit design decisions
are made that value generalizability beyond the trial
itself.
Finally, implementation trials, in contrast to both types
of intervention trials, aim at arriving at the optimal
implementation strategy, and maximal EBP impact, by
the end of the study, rather than isolating specific mech-
anisms. Note, however, that in subtle ways this is the
case for all types of studies, including efficacy trials, in
which intervention fidelity data are assiduously collected
throughout the study and adjustments in training and
even personnel are made to ensure internal validity. The
difference with implementation trials is that such modi-
fications are planned for through formative evaluation,
and often specifically hypothesized about [31].
Hybrid effectiveness-implementation trial designs
Although an implementation research protocol can
demonstrate improvements in the uptake of EBPs, the
impact of such practices on health outcomes has not
classically been a concern of implementation science.
However, it is clear from many studies that the assump-
tion that improved processes mean improved health out-
comes is flawed [59, 60]. Additionally, even if EBPs are
implemented as planned with adequate fidelity, there
may be a “voltage drop” as an EBP moves from the ef-
fectiveness clinical trials setting into implementation in
real-world clinical practices. Moreover, it is important to
know the degree to which an EBP, when utilized in gen-
eral clinical practice, retains the active mechanisms
while adapting to local site needs and priorities [61, 62].
Cognizant of these needs, a group of implementation
and clinical trial researchers codified the concept of
hybrid effectiveness-implementation designs [63].
“Codify” is the correct term, rather than “develop,” since
all the concepts and methodologies involved in hybrid
designs already existed across often disparate scientific
fields; the purpose of the hybrid design concept paper
was to bring together those concepts and methodologies
into a single framework and explore the utility of the
framework for the needs of real-world researchers and
public health stakeholders. In a few short years this
framework has begun to be adopted by researchers and
funders [64].
Hybrid research designs are defined as trial designs
that take a dual focus a priori of assessing both the
effectiveness of the implementation strategy in enhan-
cing the use of the EBP and the health impact of the
EBP [63]. Thus hybrid designs pose hypotheses regard-
ing both EBP and implementation effects, typically
measuring both healthcare processes (implementation
outcomes) and health status (intervention outcomes).
Not all hybrid designs apply controlled trial methodolo-
gies to both aspects of outcome simultaneously, but all
incorporate a priori the assessment of both of these
domains explicitly during the development of the
research design. There are three types of hybrid designs.
Hybrid Type I designs test the health impact of an EBP
while explicitly collecting data on the implementation
process to facilitate subsequent implementation efforts.
Such designs are typically utilized preliminary to an
implementation trial. Some advocates say that all effect-
iveness trials should be Hybrid Type Is.
Hybrid Type III designs test the ability of an imple-
mentation strategy to enhance use of an EBP while col-
lecting data on health impact of the EBP during
implementation. These designs are useful when the
effectiveness of an intervention is well established, but it
is unclear how robust the effects are likely to be under
implementation conditions. Some advocates say that all
implementation trials that involve processes to improve
health outcomes should be Hybrid Type IIIs.
Hybrid Type II designs are a hybrid of hybrids: They
test both the EBP effects on health outcome and the
implementation strategy effects on EBP use. Such
designs are utilized when there is substantial “implemen-
tation momentum” within a clinical system, but inter-
vention effectiveness data are somewhat less extensive or
only indirect. Thus both the impact of the implementa-
tion strategy on EBP usage and the impact of the EBP
on health status are the dual foci of Hybrid Type II
designs.
Two real-world implementation study examples
A brief description of two USVA QUERI projects will
illustrate some of the concepts covered in this review.
Incentives in substance use disorders (Illustrating a type I
hybrid design)
The first exemplar [65, 66] is an effectiveness trial with
an observational implementation component fully inte-
grated into its design (Hybrid Type I). The rationale
behind adding the implementation component to this
trial was that if the intervention proved to be effective,
information on the most feasible strategies for imple-
mentation and the most significant barriers likely to be
encountered would already be collected, informing
future implementation efforts. As the methods of the
randomized, controlled effectiveness trial portion of the
study are standard and familiar to most researchers (see
also Table 3), this description will focus on the process
evaluation. The process evaluation was guided by two
frameworks. RE-AIM [67] guided the investigator to
examine the Reach, Effectiveness, Adoption, Implemen-
tation and Maintenance of the intervention, posing
questions such as how many patients will be interested
in receiving the intervention, what information will a
clinic require to consider adoption of the intervention,
Bauer et al. BMC Psychology  (2015) 3:32 Page 8 of 12
which training, tools and/or resources will the clinic
require to implement the proposed intervention with
high fidelity and what resources will be required for the
clinic to maintain the intervention long-term. In com-
plementary fashion, the PARIHS framework (Promoting
Action on Research Implementation in Health Services
[68]; recently revised [69]) proposes that successful im-
plementation is a function of the strength of the evi-
dence supporting the intervention, the context in which
the intervention is implemented and the facilitation pro-
vided to support implementation. These constructs
guided the investigators to determine how the evidence
base for the intervention is perceived by practitioners,
which characteristics of the context impeded or facili-
tated implementation, and which tools and supports
facilitated dealing with identified barriers.
The process evaluation for this study combined multiple
data collection tools and strategies in an attempt to iden-
tify key barriers and facilitators related to each of these
constructs. Data collection tools included administrative
data, patient surveys, staff surveys and interviews, clinic
leadership interviews and cost tracking data. Information
from these multiple sources allowed the identification of
key barriers and facilitators likely to be encountered in
any efforts to implement the incentive intervention in
additional clinics and allowed for the creation of recom-
mended implementation strategies (Table 4).
Implementing pharmacotherapy for alcohol use disorders
(illustrating formative evaluation)
The second example is an ongoing implementation trial
that uses formative evaluation techniques to refine and
test a theory-driven implementation strategy to increase
access to alcohol use disorder pharmacotherapy in pri-
mary care settings. The rationale for including the for-
mative evaluation was that no matter how carefully an
implementation strategy is planned in advance, the
experience of actual implementation leads to insights
which can be utilized to improve the strategy even fur-
ther. The development of the initial strategy was based
on prior formative QUERI work as well as the Theory of
Planned Behavior [70]. Earlier qualitative interviews with
providers had documented: (1) lack of provider confi-
dence in medication effectiveness, (2) lack of provider
skills and knowledge about using the medications, and
(3) perceived low patient demand as the top three bar-
riers to implementation. This work suggested that
implementation interventions would have to focus not
only on education but also on “marketing” and that the
interventions would need to focus not only on providers
but also on patients.
The Theory of Planned Behavior was used as a guiding
theory because the desired behavior change is primarily
at the individual level, e.g., convincing providers and
patients to consider pharmacotherapy as a viable inter-
vention option for alcohol use disorders. The Theory of
Planned Behavior states that behavioral intentions are
guided by attitudes toward the behavior, subjective peer
Table 4 Enhancing Implementation of Incentive Therapy for
Substance Use Disorders Guided by the RE-AIM & PARIHS
Frameworks (Section VI.A)
RE-AIM Framework [67]
Reach • Target intervention to patients that will be attending
treatment at least twice • per week for other
treatment services.
Adoption • Solicit explicit support from the highest levels of the
organization through, for example, performance
measures or treatment recommendations.
• Identify or create measures of clinic effectiveness
which can be used to identify gaps in performance
and monitor the impact of implementation.
• Solicit agreement in advance for designated funding.
• Educate leadership about potential strategies for
integrating the intervention into current practices.
• Adopt incrementally. Start with a specific treatment
track or clinic to reduce staff and funding burden
until local evidence of effectiveness and feasibility is
available to support spread
Implementation • Train staff on urine test cups and breathalyzer
including sensitivity and specificity of the screen
results.
• Make scripts available for communicating positive
and negative test results to patients.
• Supply a tracking database to ensure consistency in
awarding prize picks.
• Provide a step by step intervention appointment
protocol.
• Facilitate documentation in the electronic health
record.
Maintenance • Ensure all staff are aware of their responsibilities
related to incorporating information from the
intervention into clinical interactions with patients to
facilitate integration into the clinic.
• Consider option of having case managers administer
the intervention to their own patients rather than
having one or two individuals responsible for the
intervention.
PARIHS Framework [68, 69]
Evidence • Staff may not be aware of strength of evidence or
may express philosophical disagreement with
incentive interventions: Engage staff early on to
understand and address concerns.
• Staff may need education on evidence and/or how
behavioral reinforcements function in a variety of
settings.
• Staff may benefit from engaging with clinics that
have already implemented or may be willing to
engage in a brief test of the intervention.
Context • Even in highly supportive contexts, barriers are
substantial and implementation has a high likelihood
of failure if barriers are not identified and addressed
up front.
Bauer et al. BMC Psychology  (2015) 3:32 Page 9 of 12
norms, and perceived behavioral control and implemen-
tation interventions were selected to address each of
these constructs. Implementation strategies selected for
providers include social marketing, access to peer expert
consultants, feedback on prescribing rates, and educa-
tion and decision support tools. Direct-to-consumer
mailings were selected as the intervention to address
lack of patient awareness of medication options and po-
tential negative peer attitudes toward pharmacological
treatment of alcohol use disorder and to encourage
patients to discuss alcohol use with their primary care
provider. The implementation strategy is being evaluated
using an interrupted time-series design with controls.
Prescribing rates are being monitored for 9-month
pre-implementation, implementation, and post-
implementation phases for intervention facilities and
matched control facilities. Already in the study, forma-
tive evaluation has led to refinements of the imple-
mentation strategy (Table 5).
Summary
Healthcare environments around the world are increasingly
dynamic, resource-constrained, and interconnected—
and are driven by equally complex political and eco-
nomic environments. Accordingly, maximizing health-
care value [19] has become a policy imperative globally.
Healthcare sciences must evolve in parallel to serve this
need.
To this end, implementation science is becoming a crit-
ical tool for promoting what the US Institute of Medicine
has called the “Learning Healthcare System.” The learning
healthcare system can be defined as a healthcare system
that employs a set of ongoing processes to provide higher
value healthcare through systematic review of health care
data analytics, and application of such data to inform pro-
motion of overall strategies and targeted improvement ef-
forts [71, 72].
To date, the bulk of attention to learning healthcare
systems has focused on the acquisition and analysis of
large datasets gathered from real-world clinical prac-
tices in as close to real-time as possible [73]. However,
such data-gathering represents only the input arm of
the learning healthcare organization. Healthcare sys-
tems also need to act on such data to improve practice.
Implementation science provides a systematic set of
principles and methods by which to accomplish this.
Provider and system behavior do not change by them-
selves, and unimodal interventions do not typically pro-
duce effective or lasting changes in systems as complex as
healthcare [39]. Without concerted attention to evidence-
based implementation strategies, learning healthcare sys-
tems risk developing massive, expensive repositories of
information without adequate strategies to actually
utilize such data for system change. As with earlier as-
sumptions that mere publication of an efficacy or ef-
fectiveness trial results would lead to automatic EBP
adoption, the assumption that comprehensive, elegant,
real-time datasets will, in and of themselves, lead to
practice change is at best an optimistic aspiration and
at worst a massively expensive error.
Rather, sophisticated data-gathering systems must be
paired with equally sophisticated implementation strat-
egies if learning healthcare systems are to make good on
their promise. The emerging science of implementation
provides a systematized approach to identifying and
addressing barriers and facilitators to system change,
and thus represents a critical component of any learning
healthcare system.
Table 5 Developmental Formative Evaluation: The Example of Pharmacotherapy for Alcohol Use Disorders (Section VI.B)
Key Barriers Identified (Exemplar Quote) Resulting Implementation Refinements
Lack of time: “I don’t have time for this. Patients are not coming in
asking to address their alcohol use. I’d be lucky to have 5 min to discuss
this.”
• Condense educational materials.
• Make materials available through link in computerized record provider
will already have open.
• Present research demonstrating that brief conversations can reduce
patient drinking levels.
Do not perceive current system as problematic: “The system works fine
as it is. We have great substance use disorder folks to refer them to.”
• Data to demonstrate that majority of patients do not follow through on
referrals.
• Education on patient perspective: Patients that are not comfortable
going to “addiction” or “mental health” clinic may address alcohol use as
part of overall plan for improving health.
Perceived lack of patient interest: “Patients are not going to be happy
with me if I bring this up. They don’t want to talk about it.”
• Present patient interview results: Patients want more information and
would accept this information from their primary care provider.
Lack of proficiency: “I was never trained to deal with addictions. This is
not in my purview.”
• Comprehensive education and consultation from peer specialists.
• Stress impact of alcohol use on major diseases that they struggle to
manage on a daily basis.
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